Becher Charles
SEC CIK 1775310 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| SONM | DNA X, Inc. | See Remarks | 62.7K | — | $45.4K | 3 | 2023-12-26 | 2025-04-23 |
Most active insiders at SONM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Crolius Clayton | CFO | — | — |
| 2 | MULICA MICHAEL C | Acting CEO, Dir | — | — |
Becher Charles made no open-market trades at SONM in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-04-25 | 2025-04-23 | SONM | DNA X, Inc. | Becher Charles | See Remarks | S - Sale | $1.45 | -31.3K | 62.7K | -33% | -$45.4K | |
| 2025-02-10 | 2025-02-06 | SONM | DNA X, Inc. | Becher Charles | See Remarks | A - Grant | $0.00 | +70.7K | 94.0K | +303% | $0 | |
| D | 2023-12-28 | 2023-12-26 | SONM | DNA X, Inc. | Becher Charles | See Remarks | M - OptEx | $0.42 | +125.0K | 233.2K | +115% | +$52.5K |
Purchase Sale Sale after option exercise All abbreviations